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Abstract
Background: The Every Newborn Action Plan (ENAP), launched in 2014, aims to end preventable newborn deaths
and stillbirths, with national targets of ≤12 neonatal deaths per 1000 live births and ≤12 stillbirths per 1000 total
births by 2030. This requires ambitious improvement of the data on care at birth and of small and sick newborns,
particularly to track coverage, quality and equity.
Methods: In a multistage process, a matrix of 70 indicators were assessed by the Every Newborn steering group.
Indicators were graded based on their availability and importance to ENAP, resulting in 10 core and 10 additional
indicators. A consultation process was undertaken to assess the status of each ENAP core indicator definition, data
availability and measurement feasibility. Coverage indicators for the specific ENAP treatment interventions were
assigned task teams and given priority as they were identified as requiring the most technical work. Consultations
were held throughout.
Results: ENAP published 10 core indicators plus 10 additional indicators. Three core impact indicators (neonatal
mortality rate, maternal mortality ratio, stillbirth rate) are well defined, with future efforts needed to focus on
improving data quantity and quality. Three core indicators on coverage of care for all mothers and newborns
(intrapartum/skilled birth attendance, early postnatal care, essential newborn care) have defined contact points, but
gaps exist in measuring content and quality of the interventions. Four core (antenatal corticosteroids, neonatal
resuscitation, treatment of serious neonatal infections, kangaroo mother care) and one additional coverage
indicator for newborns at risk or with complications (chlorhexidine cord cleansing) lack indicator definitions or data,
especially for denominators (population in need). To address these gaps, feasible coverage indicator definitions are
presented for validity testing. Measurable process indicators to help monitor health service readiness are also
presented. A major measurement gap exists to monitor care of small and sick babies, yet signal functions could be
tracked similarly to emergency obstetric care.
Conclusions: The ENAP Measurement Improvement Roadmap (2015-2020) outlines tools to be developed (e.g.,
improved birth and death registration, audit, and minimum perinatal dataset) and actions to test, validate and
institutionalise proposed coverage indicators. The roadmap presents a unique opportunity to strengthen routine
health information systems, crosslinking these data with civil registration and vital statistics and population-based
surveys. Real measurement change requires intentional transfer of leadership to countries with the greatest disease
burden and will be achieved by working with centres of excellence and existing networks.
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Background
The close of the Millennium Development Goals
(MDGs), with a halving of maternal mortality and under
five child deaths, demonstrates that global targets are
linked to national and global accountability and can drive
change. Under-five deaths due to HIV/AIDS, malaria and
measles (among others), have seen the greatest propor-
tional declines [1]. Where indicators for high impact, evi-
dence-based interventions are carefully tracked, previous
analysis has demonstrated that coverage tends to
improve, largely due to focused policy attention, invest-
ment and informed planning, leading to better popula-
tion health outcomes [2]. Interventions for child health
and causes of child death have had more programmatic
data (coverage and process), collected more frequently, at
a more granular level (e.g. district level, by various equity
analyses groups), than for newborn health, where the
data is of poorer quantity and quality, and has been col-
lected with less frequency [3].
As the MDGs transition to the Sustainable Development
Goals (SDGs), there remains an unfinished agenda for 2.7
million neonatal deaths, for whom progress has been
much slower than progress towards reducing the overall
under 5 mortality rate. An estimated 2.6 million stillbirths
were not counted at all in the MDGs[4]. Well-functioning
civil registration and vital statistics (CRVS) systems gener-
ate policy, ensure access to services and are associated
with better health outcomes worldwide [5]; counting
births and deaths, especially the deaths around the time of
birth, lies at the heart of post-2015 health monitoring,
accountability and action [3]. Tracking vital events and
measuring coverage is also central to developing national
health management information systems (HMIS), such as
in the Measurement and Accountability for Results in
Health (MA4Health) Roadmap [6], which aims to increase
investment in national data systems and data use.
The Every Newborn Action Plan (ENAP) [7] is a global
multi-partner movement to end preventable maternal
and newborn deaths and stillbirths. Through a series of
consultations, multiple stakeholders (governments, Uni-
ted Nations (UN) agencies, donors, business commu-
nities, professional associations, academic and research
institutions, global initiatives and civil society members)
developed an impact framework and an action and mea-
surement agenda for integration within national newborn
health plans [3,8].
To reach 2030 national targets for neonatal mortality
and stillbirth rates of ≤12 per 1000 births, high and equi-
table coverage of the evidence-based interventions identi-
fied by ENAP is needed [9]. ENAP prioritises achieving
universal coverage of these interventions particularly dur-
ing childbirth and the first week of life. Yet many of these
interventions are not systematically measured. One of the
five ENAP strategic objectives - to count every newborn
(and birth) - underlines the need for improved data and
accountability. The ENAP milestones, linked to a World
Health Assembly resolution [7], have a particular focus
on inputs required prior to 2020 and more than half refer
to improving metrics for targeting and driving change
(Figure 1). One such milestone is to develop a monitor-
ing framework building on the Commission on Informa-
tion and Accountability (COIA) for Women’s and
Children’s Health [10] to track global progress post 2015
and align with country priorities and objectives.
The principal focus of this paper is based on the ENAP
milestone to define and improve priority coverage indica-
tors, as this was where the largest measurement gaps
were identified. Many newborn care interventions lack
standard indicator definitions and are not routinely mon-
itored at national or global level, especially in low and
middle-income countries (LMIC). We define a coverage
indicator as a population-level metric that measures the
number of individuals that receive an intervention or ser-
vice (numerator) out of a total population that should
receive the intervention or service (the denominator). For
the numerator, indicators rely on clear technical defini-
tions of the service or intervention. Where there is diffi-
culty capturing the population in need (the denominator)
particularly for specific treatment interventions, some
indicators (such as the caesarean-section rate) use total
live births as the denominator to give a proxy. In such
cases, where the aim is not for 100% coverage, the rate is
then benchmarked against a target threshold.
The coverage indicators prioritised by the Commission
for Information and Accountability (COIA) mainly reflect
contact points along the continuum of care, notably
antenatal care, skilled birth attendance and postnatal
care. Such coverage indicators capture contact with the
health system or delivery of a specific intervention, but
not always detailed, accurate information on the content
or quality of the care delivered [11], although antenatal
care now has a detailed content module within the
Demographic and Health Survey (DHS) [12]. In high-
burden countries the main current data source is through
household surveys. The most commonly employed
household surveys are the United States Agency for
International Development (USAID)-supported DHS [13]
and the United Nations International Children’s Fund
(UNICEF)-supported Multiple Indicator Cluster Survey
(MICS) [14]. However, coverage of many maternal and
newborn interventions cannot feasibly and/or accurately
be collected through household surveys.
For health information collected through household
surveys, the data quality usually depends on the validity
of the mother’s report, often up to two to five years after
the intervention occurred. There is evidence suggesting
that maternal recall of events that occurred during labour
is poor [12], especially if there were complications. In
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addition, how the question is asked can affect the accu-
racy of the response. For surveys, large sample sizes are
needed to generate sufficient statistical power to assess
social and demographic factors. Bryce et al: [15]
described some of the limitations of household surveys
for measuring coverage of interventions, including the
time, cost and limited validity (sensitivity and specificity)
of many of the indicators.
Health facility assessments (HFAs) are frequently used to
complement HMIS, facility-based logistics and service
delivery information systems. These provide information
on staffing, equipment availability, spatial organisation,
data collection capacity, and service readiness. A number
of standardised HFA tools exist, the most commonly
employed being the Service Availability and Readiness
Assessment (SARA) [16], Service Provision Assessments
(SPA) [17] and the Emergency Obstetric Care (EmOC)
needs assessments [18]. These allow health systems to
report on a sample of facilities that provide a certain ser-
vice or have health workers trained in specific skills, but
are not routine reporting mechanisms. In addition, the
WHO Health Access/Action International database has
data on medication availability. Service availability and
quality indicators provide complementary metrics to popu-
lation coverage which can be used to ensure that services
achieve adequate coverage and give due attention to the
availability of care, and the readiness of facilities to deliver
the safe and quality care that is fundamental to the Every
Newborn movement.
Since coverage of evidence-based care for mothers and
newborns is often unknown, or data may be old or not
locally available, this is a major “bottleneck”, impeding
scale up of high-impact, evidence-based interventions for
newborns. Such data have been critical in accelerating pro-
gress in the implementation and scale-up of immunisation
and HIV programmes through increased policy attention,
focused investment of resources and better accountability
structures [15]. Such data are critical for informed plan-
ning, driving programme improvement and targeting
underserved populations to reduce inequities.
Figure 1 Every Newborn Action Plan (ENAP) Measurement Improvement Roadmap: the arc of change. In support of Health Measurement
and Accountability post-2015: A Common Roadmap WHO (2015) [6]. ENAP: Every Newborn Action Plan; WHO: World Health Organization.
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The objectives of this paper are to:
1. Describe the systematic process used to select
ENAP indicators and present the core and additional
indicators.
2. Assess the status (technical definitions and data
availability) of the ENAP coverage indicators and
identify actions needed to improve these for mea-
surement at scale, particularly for coverage of the
treatment interventions.
3. Identify priorities for testing validity and feasibil-
ity, in order to institutionalise these metrics within
large scale data collection platforms and outline a
five-year measurement improvement roadmap.
Methods
Objective 1: systematically grade to select the ENAP core
and additional indicators
A multi-stage process was carried out to identify a list of
potential indicators and then prioritise a short list. This
process involved a working group appointed by the ENAP
management team who compiled a comprehensive list of
indicators, drawing on existing databases such as COIA
[10], UNICEF’s State of the World’s Children (SoWC)
[19], Countdown to 2015 [20] and other World Health
Organization (WHO) statistics and reports. Standardised,
nationally representative survey tools currently in use
(MICS, DHS, SPA, SARA and EmOC surveys) were con-
sidered as sources of data. In addition, possible indicators
relating to common causes of neonatal death were
included. This resulted in a matrix of over 70 relevant
indicators measuring impact (mortality and morbidity),
outcome (coverage of care for all babies and coverage of
treatment interventions), outputs (service quality, availabil-
ity, demand, and the enabling environment) and inputs
(human resources, essential medicines and supplies) (see
Additional file 1). The current status of definitions, mea-
surability and data availability were reviewed for each of
the proposed indicators.
A systematic scoring process was applied to prioritise
core indicators that could track the main focus of the
action plan, particularly on quality of care at birth and
the five strategic objectives. Each indicator was graded by
its importance to the ENAP focus (A to C) and by cur-
rent data availability (1 to 3). A grade of A was given to
indicators of highest relevance and match to the ENAP
focus and a score of 1 was given to indicators with a
common and consistent definition already measured in
existing data sources. Scoring was completed by an
expert working group and decided via group consensus
with priority given to indicators in terms of their rele-
vance to the ENAP focus, rather than data availability.
Given the principle of accelerating impact, a decision
was taken to focus on a shorter list of important indicators
and ensure those would be made measureable, rather than
to just select those that were already measureable. Hence,
indicators were prioritised first based on their importance
to the ENAP focus (category A) and then on data availabil-
ity. Indicators in Category A ranged from those with defi-
nitions and existing data (availability 1) to those without
standard definitions and existing data (availability 2 or 3).
The latter were identified as having priority measurement
gaps that needed to be addressed with a specific program
of work.
Objective 2: assess status of ENAP coverage indicators
and identify priorities to improve measurement at scale
For each of five high impact interventions identified with
the greatest measurement gap (red box in Figure 2), a
Task Team was established. These included antenatal
corticosteroids (ACS), newborn resuscitation, Kangaroo
Mother Care (KMC), case management of serious neona-
tal infection and chlorhexidine cord cleansing. The Task
Teams sought to represent both the maternal and new-
born health communities and reflect multiple stake-
holders, e.g. non-governmental organisations, UN
organisations, professional associations, and research
institutions; ensuring representation from LMIC. With
the support of the ENAP metrics coordination group,
Task Teams carried out a consultation process to define
indicators based on a technical definition, suggest feasible
indicators that can be measured now through existing
data collection platforms, and outline research priorities
to test validity and feasibility for these coverage metrics
for each area, including data collection tools.
WHO hosted a consultation at a meeting in Geneva,
December 2014 to review the work of the Task Teams,
and also gain inputs on the other core indicators. This
meeting developed a draft plan to deliver on the ENAP
metrics milestones, including discussion on the specific
actions needed to improve coverage indicators. Plans for
improving measurement tools and tracking systems
were also discussed; for example, perinatal audit tools,
neonatal care registers and Civil Registration and Vital
Statistic (CRVS) improvements. The draft plan was then
advanced by those at the meeting and through wider
consultation.
The priorities for testing validity and feasibility to
institutionalise these metrics within large scale data col-
lection platforms and the measurement improvement
roadmap (Objective 3) are discussed in detail in the dis-
cussion section of this paper.
Results
Objective 1: systematically grade to select the ENAP core
and additional indicators
Following the process described above, ENAP listed 10
core indicators (Figure 2). For the three impact
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indicators that already have agreed definitions (Figure 3),
the priority is for improved quality and quantity of data.
There is increasing consensus on the need to invest in
CRVS and linked facility-based tracking to improve relia-
bility of impact indicators [3,4,21].
The principal focus of this paper is on the coverage
indicators, where the largest metrics gaps were identified.
The coverage indicators fall into two groups: key contact
points for care for all mothers and newborns (Figure 4),
and specific treatment interventions (mainly for care for
newborns at risk or with complications) (Figure 5 and 6).
For essential newborn care, early initiation of breastfeed-
ing was identified as a tracer indicator, with exclusive
breastfeeding up to 6 months as an additional indicator.
Chlorhexidine cord cleansing was also added to the
improvement agenda, given the gaps in coverage data.
Objective 2: assess status of ENAP coverage indicators,
and identify priorities to improve measurement at scale
For each coverage indicator, we describe technical defi-
nitions, current data availability, improvements needed
and steps to be taken.
Coverage: care of all mothers and newborns
(contact points)
Intrapartum care
Technical definition of package
A package of support and healthcare around the time of
birth integral to maintaining perinatal and maternal
safety along the continuum of care [9,22]. Skilled birth
attendance is used as the contact point indicator to
monitor coverage of this care.
Indicator to track contact point
A skilled birth attendant (SBA) is described by the WHO
as an accredited health professional (such as a midwife,
doctor or nurse) educated and trained to proficiency in
the skills needed to manage normal (uncomplicated)
pregnancies, childbirth and the immediate postnatal per-
iod and in the identification, management and referral of
complications in women and newborns [23].
Current data availability
SBA data are available mostly from DHS, MICS, and are
reported in many UN documents and by the Countdown
to 2015 report series, which charts country progress
towards meeting MDG goals and targets. However, no
robust time series has been published for all countries for
the MDG era to date, although SBA was the main indica-
tor under MDG5 for maternal health. Of 75 countries
participating in Countdown, all but 15 provide equity
analysis in relation to the coverage of SBA [20] (countries
who do not report equity compared with SBA coverage
are: Angola, Botswana, Brazil, China, Djibouti, Equatorial
Guinea, Eritrea, Korea, Mexico, Myanmar, Papua New
Guinea, Solomon Islands, South Sudan, Sudan and Turk-
menistan). These suggest SBA coverage has the widest
equity gap for any contact point along the COIA conti-
nuum of care indicators [20]. SPA also has a new
optional observational module for labour and delivery
care that has been applied in Kenya, Malawi and Bangla-
desh developed by the Maternal and Child Health
Figure 2 Every Newborn Action Plan (ENAP) core and additional indicators. Shaded= Not currently routinely tracked at global level. Bold
red= Indicator requiring additional testing to inform consistent measurement. Indicators to be disaggregated by equity such as urban/rural,
income and education. Adapted from WHO and UNICEF, Every Newborn Action Plan. WHO, 2014. http://www.everynewborn.org/ and Mason
et al: Lancet 2014.
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Integrated Program (MCHIP) that provides supplemen-
tary data for assessment of quality of care.
What can we do to improve the data?
While WHO’s definition of a SBA has a defined list of
core midwifery skills [18], measurement of SBA is chal-
lenged by the variety of cadres included in the definition
and the lack of consistency in training, skills and core
functions across countries [24]. Besides doctors, nurses
and midwifes, there are several other country specific
cadres of auxiliary midwifes, medical assistants and
other health professionals that are included in the SBA
category in many countries; these may also be subject to
Figure 3 Every Newborn Action Plan (ENAP) core indicators regarding impact, with definitions and data sources. Shaded= Not currently
routinely tracked at global level. Bold= indicator requiring additional evaluation for consistent measurement. *The time period will normally be
calculated per year. **ICD assumes weight and gestational age are equivalent, which they are not (see Stillbirth series Lawn et al: 2011). ICD:
International Classification of Disease; UNFPA: United Nations Population Fund; UNICEF: United Nations International Children’s Emergency Fund;
WHO: World Health Organization.
Figure 4 Every Newborn Action Plan (ENAP) core indicators regarding coverage of care for all mothers and newborns, with definitions
and data sources. DHS: Demographic and Health Survey; MICS: Multiple Indicator Cluster Survey.
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change over time, or across survey programmes. Current
work towards standardising the professional remit of
SBAs and foster more universal accountability mechan-
isms are being carried out by WHO, UNICEF and
UNFPA. Expert consultations will be held in late 2015
to discuss operational definitions and develop measure-
ment guidance for survey programmes.
In addition, SBA is an indicator of contact with the
health system and does not provide information on the
content or quality of care making it an incomplete and
misleading proxy for quality of care at birth [12]; addi-
tional information about equipment, provider skills,
referral availability, content of care and other measures
of quality are also required. Process indicators on facility
readiness are collected by SPA, SARA and EmOC needs
assessments (Figure 4) though the range of data col-
lected varies between surveys and there is limited focus
on newborn care. Current DHS and MICS survey tools
do not collect extensive data on the content of care at
time of birth [12]; therefore, increasing the capacity and
availability of routine facility level data is a priority for
improvement.
Early postnatal care
Technical definition of package
A package of healthcare provided to women and their
newborn either at the facility or during consultation at
home. For women who deliver at a health facility, WHO
recommendations support inpatient care for at least 24
hours, and/or provision of care as early as possible and
Figure 5 Every Newborn Action Plan (ENAP) core indicators regarding coverage of care for newborns at risk or with complications,
with definitions and data sources. Blue coloured cells= not currently tracked and collated by United Nations. Bold italics= indicator needing
further work to ensure availability of consistent data in routine information systems. All coverage indicators to be tracked in such a way that
they can be broken down to assess equity- e.g. urban or rural, regional, wealth quintile. ACS: antenatal corticosteroids; GA: gestational age; HMIS:
Health Management Information System; KMC: kangaroo mother care; QoC: quality of care; SARA: Service Availability and Readiness Assessments;
SPA: Service Provision Assessments; WHO: World Health Organization.
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at least within 24 hours for women and newborns who
are born at home [25].
Indicator to track contact point
Early postnatal care is defined as a contact provided to a
woman and her newborn during the 2 days (48 hours)
following birth (whether in a facility or at home) (see
Figure 4) and excludes immediate postpartum care [13].
Current data availability
The early postnatal care contact point is measured in
household surveys as two separate indicators (a postna-
tal health check for the newborn and a postnatal health
check for the mother) tracking coverage of a first post-
natal contact within 2 days of delivery. The questions
used to derive this indicator have changed significantly
over time and have been different between the DHS and
MICS [14], however Phase 7 of DHS [13] now includes
questions allowing computation of a comparable postna-
tal care indicator.
What can we do to improve the data?
Postnatal care is a package of services for women and
babies, therefore, data on content and quality are
required in addition to tracking the contact point. One
critical question is to ensure the data can distinguish
between intrapartum and postnatal care [26]. In both
DHS and MICS, this is being attempted through the use
of question prompts to better describe the content of
the postnatal check and recent revision of the DHS core
questionnaire includes a question on the content of
PNC checks. Supplementary data pertaining to the con-
tent of care, provider skill and other quality control
measures is urgently required; a move away from inter-
mittent survey based data collection towards sustainable
HMIS is essential in ensuring that effective management
mechanisms can be facilitated and support routine qual-
ity of care tracking.
Essential newborn care
Technical definition of package
Preventive and supportive care required for all newborns
including: warmth, cleanliness, breastfeeding, cord and
eye-care, Vitamin K and immunisations [27-29].
Indicator to track care
Due to the strong evidence of a reduction in newborn
mortality and morbidity with early initiation of breastfeed-
ing, especially through decreased rates of infection [30-32],
early initiation of breastfeeding was prioritised as a tracer
indicator for essential newborn care, with exclusive breast-
feeding at 6 months as a further marker (Figure 4). Indica-
tors of other components such as skin-to-skin care, may
also be possible, and are recalled accurately by mothers
Figure 6 Every Newborn Action Plan (ENAP) core indicators regarding coverage of complications and extra care (specific treatment
indicators), with definitions and data sources. Blue coloured cells= not currently tracked and collated by United Nations. Bold italics=
indicator needing further work to ensure availability of consistent data in routine information systems. Red= service delivery package for which
norms and standards will be defined and tracked. All coverage indicators to be tracked in such a way that they can be broken down to assess
equity- e.g. urban or rural, regional, wealth quintile. CHX: chlorhexidine; DHS: Demographic and Health survey; EmOC: emergency Obstetric Care;
HMIS: Health Management Information System; MICS: Multiple Indicator Cluster Survey; UN: United Nations.
Moxon et al. BMC Pregnancy and Childbirth 2015, 15(Suppl 2):S8
http://www.biomedcentral.com/1471-2393/15/S2/S8
Page 8 of 23
[12]. However, these data are not currently widely avail-
able, and further testing is required to ensure that routine
skin-to-skin can be accurately distinguished from KMC by
survey respondents.
The WHO recommends the early initiation of breast-
feeding within one hour of birth [33] and then exclusive
breastfeeding for the first 6 months of life [34]. To sup-
port this, babies should be placed skin to skin with their
mothers immediately following birth and offered help to
breastfeed when needed [35].
Current data availability
MICS, DHS and other national household surveys col-
lect data measuring coverage of the early initiation of
breastfeeding [1,36] and it is reported in Countdown
and SoWC [20]. Both MICS and DHS contain measure-
ment questions focusing on feeding behaviours within
the last 24 hours from the time of survey. This approach
allows for more accurate recall of the behaviour, how-
ever, does not capture breastfeeding practises across the
infant time period and, therefore, the results may not
reflect breastfeeding practises over time.
What can we do to improve the data?
A recent validation study reported that the early initia-
tion of breastfeeding indicator had high sensitivity (0.82)
but poor specificity (0.25), using a household survey
instrument [12]. Although the instrument used in the
study posed a slightly different question than what is in
DHS, this suggests a need for further testing and valida-
tion. Additional research to determine the impact of
other essential newborn care practices would enable
more informed and targeted behaviour change and asso-
ciated measurement approaches.
Coverage: care for newborns at risk or with
complications (specific treatment interventions)
Antenatal corticosteroids
Technical definition of intervention
Currently, antenatal corticosteroid therapy (ACS) (24 mg
of intramuscular dexamethasone or betamethasone in
divided doses over 24 hours) is recommended by WHO
for all mothers at risk of imminent preterm birth (delivery
before 34 completed weeks of gestation) when the mother
is in a facility where accurate gestational age can be
obtained, where there is no clinical evidence of maternal
infection, and there are adequate levels of maternity care
and special newborn care available [37] (WHO guidelines
are currently being revised). These guidelines reflect
changes after the Antenatal Corticosteroids Trial (ACT)
which evaluated prescription of ACS at lower levels of the
health system, with approximately half of births occurring
at home, and found a risk of adverse outcomes especially
amongst births after 34 completed weeks of gestation [38].
This trial underlines the importance of measuring gesta-
tional age, and better tracking of coverage and outcomes.
Current coverage data availability
Coverage data on provision of ACS for neonatal admis-
sions are routinely collected within most high income
countries (HIC), but are not consistently part of HMIS
or standardised facility surveys. Since the intervention is
used in health facilities [38], improved facility level data
are a priority for capturing ACS coverage. Household
surveys are unlikely to be a useful source for this infor-
mation, as mothers may not accurately report ACS
(with difficulties to differentiate between ACS and other
drugs given at the time of labour). In addition, data may
have low statistical power given the relatively small
numbers in the population who receive ACS for fetal
lung maturation [12].
Process indicator to track now
In many LMICs, where HMIS does not capture ACS cov-
erage, a commodities-based process indicator can be mea-
sured for tracking in the short term; SARA and SPA
includes the availability of dexamethasone within their
facility checklist. WHO Health Access/Action Interna-
tional database also collect data on availability of dexa-
methasone and betamethasone in their existing pharmacy
and facility audits [39]. However, a denominator of all
health facilities may not be fully accurate as not all facil-
ities would meet WHO criteria for safe provision of ACS
(see definition above), including provision of appropriate
maternal and newborn care [1,40]. Countdown reports the
number of countries whose national policy recommends
antenatal corticosteroids for preterm labour [1]. While this
indicator is distal to coverage, it is available and helpful in
tracking changes in policy context (Figure 5).
What can we do to improve the data?
It is challenging to define a precise indicator that can
capture both eligible women who should receive ACS
and measure ACS provision. Recent evidence suggests
use of ACS may be associated with a risk of adverse out-
comes for babies whose gestational age is ≥34 completed
weeks [38]. A major challenge is defining the denomina-
tor of eligible mothers presenting in labour <34 weeks. In
LMICs, the recall of last menstrual period (LMP) is often
poor or inaccurate in settings with low rates of literacy
and antenatal care. Access to ultrasonography is low and
mothers frequently present for ANC late in pregnancy,
when ultrasound dating is inaccurate. Thus improved
assessment of gestational age before and/or after birth,
and documentation of gestational age in medical records,
is an urgent priority in all settings irrespective of resource
availability, along with improved tracking of safety and
non-fatal outcomes. Studies are needed to validate differ-
ent and feasible methods of ascertaining gestational age
compared to accurate gestational age dating (early ultra-
sonography) in LMIC. Furthermore, methods require
validation in different regions and in settings with high
rates of fetal growth restriction.
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Thus, present capacity within most LMICs may only
extend to crude coverage of ACS (e.g. all mothers who
received 1 dose) and will not differentiate between those
who received ACS before (true positives), or after (false
positives) 34 weeks completed gestation. To capture such
information, existing datasets from high or middle income
countries may be analysed to facilitate the development
and testing of a more refined indicator. Improved gesta-
tional age assessment and documentation is needed in all
settings irrespective of resource availability, along with
improved tracking of safety and non-fatal outcomes.
Observation of facility births in a number of countries
would allow for testing and validation of a number of
options for the denominator (Figure 5). The measure-
ment improvement roadmap aims to assess whether
using these denominators is feasible in routine HMIS,
and the extent to which proposed options for testing
yield useful programmatic tracking information.
As with many of the treatment intervention coverage
indicators, the option of using all live births as a denomi-
nator will not give accurate population-representative
treatment coverage in settings where reporting in HMIS
is poor, such as settings with low facility births or a large
private sector. In such contexts it may be worth consider-
ing estimated births within a facility catchment area as
denominator, which is more challenging where popula-
tions are not well defined or birth cohorts are uncertain.
A denominator that is not restricted to the population in
need, will require definition of target coverage levels. For
ACS this target benchmark could potentially be defined
by the recent estimates of national preterm birth rate
(<34 weeks), which was shown to vary from around 4%
to 18% globally [41].
Neonatal resuscitation
Technical definition of intervention
Basic neonatal resuscitation describes assessment and
actions for every newborn at the time of birth, to assist
in establishing breathing and circulation [42]; it should
be practised on all non-macerated newborns not breath-
ing spontaneously following immediate drying in accor-
dance with current WHO guidelines [43]. Effective and
safe resuscitation of these babies is highly time-sensitive
and should be initiated within the first minute after
birth. The actions include additional stimulation and
positive pressure ventilation with bag and mask if clini-
cally indicated following stimulation [44]. The interven-
tion definition does not include advanced resuscitation
measures such as intubation and/or medications.
Current coverage data availability
National coverage data are not currently available on
neonatal resuscitation and the intervention lacks a stan-
dard measurable indicator. As with ACS, there are several
known and suspected limitations of using household
surveys to measure neonatal resuscitation coverage,
including the likely inability of mothers to report accu-
rately as they may not understand or know if their new-
born was resuscitated at birth, and small numbers
resulting in low statistical power [12,45].
Process indicator to measure now
Data on the availability of a functional newborn size bag
and mask in the delivery area of a health facility offering
maternity services may be utilised as a service readiness
indicator for neonatal resuscitation, as these data are
easy to document and already available now for many
countries (see Figure 5) [16-18]. SPA and SARA capture
the availability of at least one neonatal size bag and
mask in the labour and delivery ward (SARA captures
two sizes of masks) and neonatal resuscitation was
added to the UN EmOC signal functions in 2009 with
data collected as part of standard EmOC needs assess-
ments supported by UNICEF. Since a neonatal-size bag
and mask is on the UN essential commodities list, this
equipment is also increasingly tracked in logistics man-
agement information systems (LMIS). This indicator has
strong negative predictive value (a labour ward with no
bag and mask cannot ensure adequate resuscitation
when needed) and was recommended by the WHO con-
sultation on quality of care [46]. However, the presence
of resuscitation equipment does not equate to appropri-
ate and timely use of the neonatal bag and mask, and
not all newborns who do not breathe at birth require
positive pressure ventilation. Many newborns may
respond to stimulation alone, and there is evidence
demonstrating that the provision of resuscitation train-
ing is associated with a reduction in bag and mask use
[47]. Supplementary information regarding the presence
of staff who have received newborn resuscitation train-
ing in the last two years is collected as part of the
SARA and SPA surveys; however, these data may be dif-
ficult to compare depending on question framing
[16,17].
What can we do to improve the data?
One of the major challenges in capturing precise neona-
tal resuscitation coverage is the identification and accu-
rate measurement of a denominator that reliably
captures babies requiring resuscitation to establish
breathing after birth. As with other treatment indicators,
accurate identification of the target population depends
on correct diagnosis and classification of the individuals
in need by health care providers. Accurate classification
of babies needing resuscitation is challenging in all set-
tings due to variable diagnostic skills and experience of
individual providers [45,48]. Independent of provider
competence, this would likely be difficult data to collect
in routine systems; we can speculate that it is unlikely
that any healthcare worker would record a case where a
baby required resuscitation but did not receive it. As
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with ACS, the measurement improvement roadmap out-
lines the priority denominators for testing and the vali-
dation of observed compared with reported resuscitation
practises. Appearance, Pulse, Grimace, Activity, Respira-
tion (APGAR) scores were intended to assess the condi-
tion of the newborn after birth, but are not useful for
measuring of resuscitation for monitoring purposes as
they are not reported until 1 minute of life, after the
time within which resuscitation should be initiated. In
addition, APGAR scores may not be predictive of out-
come unless the score is very low at 5 minutes, and in
busy labour wards the scores are often recorded after
the event, if at all.
There are further challenges associated with defining a
numerator to accurately and feasibly track neonatal
resuscitation coverage. An important principle in effec-
tive and safe neonatal resuscitation is careful assessment
and stimulation of the newborn who does not start
breathing spontaneously after routine drying, and only
using bag and mask if needed in order to reduce inap-
propriate use of positive pressure ventilation [44,49,50].
However, bag and mask use may be easier to recall and
validate than distinguishing stimulation actions, such as
back rubbing, from routine drying and wrapping. A study
in Sweden found that neonatal resuscitation documenta-
tion was inadequate for reliable evaluation [51]; docu-
mentation of resuscitation is unlikely to be more
adequate in LMICs. Several countries such as Bangla-
desh, Nepal and Tanzania, propose testing collection of
routine information on newborn resuscitation by action
step. Further analysis of such efforts is likely to be useful.
Proposed testing includes comparison of health
worker documentation of newborn resuscitation actions
in facility records with observed or video recorded
resuscitation care; some of this may be possible using
existing videos from Nepal or birth records from Ban-
gladesh. New work to observe births in health facilities
across a number of countries would allow testing of the
resuscitation denominator options (Figure 5) in line
with the other treatment indicators, including various
case definitions of babies who do not breathe at birth,
or do not breathe after stimulation. A simpler denomi-
nator for resuscitation based on live births would
require defined target levels. According to estimates
(based on limited observational data) approximately 6-
10% of newborns may require some assistance to begin
breathing at birth [48,52].
Kangaroo mother care
Technical definition of intervention
A method of caring for low birthweight newborns
(mostly preterm) in direct and continuous skin-to-skin
contact, in the kangaroo position, with their mother (or
guardian), with support for early and exclusive
breastmilk feeding. The current evidence to achieve
mortality reductions supports KMC for clinically-stable
newborns, weighing less than 2000 g, initiated in a facil-
ity [53]. WHO guidelines support that the infant is
cared for in the kangaroo position for the equivalent
number weeks it would have taken for the infant to
reach full term (or as long as the baby will tolerate the
position) accompanied with appropriate follow up after
discharge [54].
Current coverage data availability
Limited data on KMC are available from facility-based sur-
veys and HMIS for several countries, including Malawi,
Dominican Republic, and El Salvador. Some middle-
income countries, especially in Latin America, have
detailed program data on KMC received, but there is no
existing standardised coverage indicator definition. There
may be differences between the level of facility in which
KMC can be safely provided or initiated and the eligibility
criteria for KMC, which creates difficulties in comparing
data between settings. Measurement of KMC is not cur-
rently carried out by routine household survey platforms.
Process indicator to measure now
Given the immediate challenges for capturing coverage,
a service-readiness indicator is proposed: the number of
facilities in which a space is identified for KMC and
where at least one staff member has received KMC
training (SPA measures within the last 2 years) (see Fig-
ure 5). This measure is similar to that defined in a
recent consultation by WHO on improving measure-
ment on the quality of maternal, newborn and child
health care in facilities [46] and is consistent with cur-
rent SARA and SPA facility assessment tools [16,17].
What can we do to improve the data?
It is possible to measure the number of newborns initiated
on facility based KMC in a number of settings through
HMIS or hospital admission records (e.g. El Salvador,
Dominican Republic, Malawi, Tanzania). However, mea-
suring a denominator of <2000 g is challenging given that
nearly half of all newborns globally are not weighed at
birth. Where birthweight is recorded, there is a known
tendency for digit preference and heaping, especially at
2500 g and 2000 g [55]. The denominator could be mea-
sured as a rate per 100 or per 1000 live births, avoiding
the difficulties of including weight in the numerator and
identifying babies in need for the denominator. However,
this doesn’t measure whether babies were truly eligible or
benefitted from KMC. Since KMC is an intervention that
benefits predominantly preterm infants, the proportion of
live births that could benefit from KMC will vary between
settings (4 to 18%); identical rates may correspond to a dif-
ferent unmet need for KMC [41].
Efforts to improve birthweight recording and gesta-
tional age assessment are integral to the scale-up and
measurement of more precise indicators for KMC.
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Existing datasets from countries with established KMC
programmes and accurate assessment of gestational age
and birthweight should be used for testing the denomi-
nators and proposed numerators (Figure 5). Linked to
the measurement improvement roadmap, developing
and validating questions for household surveys is also
important if the practice is widespread enough to ensure
a sufficient sample size. Recent work in Colombia has
shown that women can accurately and reliably recall
KMC, even decades later [56].
To develop the service readiness indicator, both the
WHO quality of care report and the KMC Acceleration
Group propose a measure of “operational” KMC [46],
although this would need further work to identify and test
its specific components. The operational indicator could
be based on available “tracers"; for example, SPA currently
collects data on allocated KMC space, infant weighing
scales, thermometer, and whether staff has received train-
ing. Other items (feeding cups, NG tubes, job aids) or
improvements to the questions on training and space
could be added where more detailed assessments are
being carried out. In Colombia, a manual of minimum,
desirable and optimal standards for KMC has been devel-
oped [57], which could be adapted for different settings.
Treatment of neonatal infection
Technical definition of intervention
The provision of antibiotics to newborns admitted for
inpatient care with possible serious bacterial infection
(pSBI), in accordance with current WHO treatment
guidelines [58,59] and diagnostic algorithms [60]. Case
management can also be considered by levels of care:
administration of oral antibiotics only, injectable antibio-
tics only, or full case management of neonatal infection
(potentially second line antibiotic therapy, IV fluids, oxy-
gen therapy, other supportive measures) [61]. Recent
trials of Simplified Antibiotic Therapy show that, where
referral is not possible, treatment with the simpler
regimes by lower level workers is feasible [62].
Current coverage data availability
Most LMICs do not collect or aggregate the number of
newborns treated for pSBI in HMIS. Household surveys,
including DHS and MICS, do not collect data on new-
borns treated for pSBI because these would likely be
unreliable (given recall issues measuring incidence of
pneumonia in children under five years) [63]. This con-
trasts with HIC settings where HMIS data is routinely
maintained with additional data points specific to moni-
toring antibiotic resistance.
Process indicator to measure now
Given challenges in measuring coverage of treatment of
serious neonatal infection, a process indicator is proposed:
the proportion of facilities in which gentamicin is available
(at a suitable peripheral level) for treatment of serious
neonatal infection [46]. This is collected by both the SPA,
SARA facility assessment tools [16,17] and the WHO
health action/access international database [39]. However,
as with resuscitation, the presence of the antibiotic in the
facility does not directly measure correct use of antibiotics
to treat newborns for pSBI or guarantee that the antibiotic
is available in paediatric doses [64].
What can we do to improve the data?
The number of newborns treated with at least one dose of
injectable antibiotic at a facility is proposed for validation
and feasibility testing against a number of denominator
options, including total live births, the number of new-
borns presenting with illness, or the number of newborns
diagnosed with pSBI (Figure 5). As treatment regimens
may vary between settings, the measurement improvement
roadmap aims to assess multiple options for a numerator
and explore the validity, feasibility and utility of using
HMIS to collect this data. For measurement of the dose of
any antibiotic, more details would be required at program
and/or facility level (rather than from the coverage indica-
tor); notably, which antibiotic(s) were used and whether
the course was completed. It will be necessary to deter-
mine appropriate use of antibiotics, as over treatment may
increase anti-microbial drug resistance. Routine, national
systems are required to track all injectable antibiotic doses
given, and those not given, with associated clinical out-
comes. A recent review found that within facility based
audits, the availability of data on neonatal specific formula-
tions (lower concentration gentamicin, procaine benzylpe-
nicillin) was scarce [64] and therefore, more data is
needed regarding the availability of neonatal formulations
and specific requirements for administration to newborns.
At first level facilities, testing of the new WHO module on
“where referral is not possible” with new simplified anti-
biotic regimens [65] will be possible in five countries
(Democratic Republic of Congo, Bangladesh, Pakistan,
Ethiopia and Nigeria). Process and quality indicators
should also be improved at the facility level, for example,
gentamicin has a narrow therapeutic index and is asso-
ciated with toxicity risks [58]; therefore, monitoring its
safe administration at program or facility level is an impor-
tant marker of quality care. Specific data on neonatal
administration of medicines (formulations, concentrations)
could also help monitor safety and quality of care in facil-
ities. In addition, where direct patient observations are car-
ried out (as with SPA for the treatment of suspected
pneumonia), this could be extended to the treatment of
serious neonatal infection in facilities to ensure health
worker compliance with IMCI guidelines [59].
Chlorhexidine cord cleansing
Technical definition of intervention
Chlorhexidine (CHX) cord cleansing is the routine
application of topical chlorhexidine digluconate 7.1%
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(solution or gel, delivering 4%) to the cord stump within
the first 24 hours of life. The WHO currently recom-
mends this intervention in settings with an NMR
>30:1000 or for homebirths [66,67].
Current coverage data availability
The recommended routine administration of chlorhexi-
dine cord cleansing is a recent policy development [25].
Data are not collected by most HMIS or as part of stan-
dardised household survey tools. Both SPA and SARA
track the availability of chlorhexidine used for general
disinfection in their commodity checklists [16,17]. Moni-
toring use of 7.1% chlorhexidine for cord cleansing
requires documentation of the presence of the specific
concentration of chlorhexidine (7.1% formulation rather
than any type of chlorhexidine product). Because of
country-specific variations in policy for routine cord
cleansing, documenting availability of 7.1% chlorhexidine
in a health facility will only be of use in settings where
programs that use chlorhexidine for umbilical cord
cleansing exist.
Process indicator to measure now
Given the current challenges in measuring coverage, the
inclusion of chlorhexidine 7.1% (solution or gel) within
national essential drug lists for the purpose of cord
cleansing has been identified as an interim process indi-
cator (Figure 6). These data are collected by the RMNCH
Trust (formerly UN Commodities Commission) and are
reported by Countdown [20]. As with ACS, this indicator
is distal and is not a measure of coverage; however, it is
an important enabling condition, data are currently avail-
able, and it would facilitate tracking of policy changes in
the coming years.
What can we do to improve the data?
Household surveys can be used to measure chlorhexidine
coverage, as carried out in Nepal [68], The number of
newborns who had chlorhexidine applied to the cord
stump within the first day of birth can be evaluated
against a denominator of live births in the survey popula-
tion. DHS has incorporated an optional five question
chlorhexidine module for countries with a national chlor-
hexidine for umbilical cord cleansing programme as part
of its newborn module. In countries where chlorhexidine
has been introduced at scale (e.g. Nepal, Bangladesh and
Nigeria), the chlorhexidine technical working group is
recommending adding a follow-up probe question speci-
fically asking about chlorhexidine use.
Refinement of both the numerator and denominator
with rigorous assessment of sensitivity and validity will
be beneficial. Showing the respondent a picture of the
locally marketed chlorhexidine during a household
interview might assist with recall, improve validity and
will be tested as part of the measurement improvement
roadmap. Due to variations in national policy on use of
chlorhexidine within facilities, further testing is required
to assess the sensitivity and specificity of household sur-
vey questions on chlorhexidine cord cleansing following
birth within a facility, where cord cleansing may have
occurred away from the mother, or performed in her
absence. Further validation will be undertaken to com-
pare observed chlorhexidine use with reported practice.
Depending on findings, longer-term efforts towards
institutionalising chlorhexidine coverage questions
within routine household survey platforms would be
essential to achieve consistent coverage data.
Discussion
The Every Newborn movement is committed to support-
ing countries to reach a target of ≤12 neonatal deaths
and stillbirths per 1000 births by 2030, also closely
linked to ending preventable maternal deaths [7]. The
ENAP metrics process has highlighted major gaps and
lack of tracking for newborn interventions at all levels
of the health management information system. To date,
insufficient technical work and investment has been
dedicated to strengthening national data systems and to
rigorous testing of coverage data. Both validation and
feasibility testing using standard research protocols for
rigorous testing are needed. The multistage ENAP
metrics process identified 10 core indicators and a set of
10 additional indicators (Figure 2). Of the core ENAP
indicators, five newborn-specific interventions are high
impact and central to ENAP, yet coverage information
is not collected through existing measurement platforms
with comparable data. Our findings highlight the prior-
ity actions required to improve ENAP indicators, espe-
cially coverage, and detail the technical and research
priorities that will enable countries to collect and use
the data in health sector review processes (Figure 1);
these findings are informing a roadmap to address mea-
surement deficits by 2020.
Measurement improvement roadmap
The ENAP measurement improvement roadmap aims to
build on existing national and global metrics work, par-
ticularly linking to maternal health metrics, whilst iden-
tifying and addressing key measurement gaps for the
focus around care at birth and care of small and sick
newborns (Figure 7). Through this process the measure-
ment improvement roadmap aims to intentionally trans-
fer data collection, management and analysis skills at a
country level (Figure 8).
Impact indicators
Impact indicators are fundamental to tracking progress
for Every Newborn. Without impact data we cannot accu-
rately measure progress towards goals to end preventable
maternal and newborn deaths and stillbirths. Child mor-
tality data have seen the most significant improvement
progress over the last decade [69]. For example, the UN
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Inter-agency Group for Child Mortality Estimation report
more than tripling input data, mostly through surveys.
ENAP milestones by 2020 include a number of tools to
link facility-based minimum perinatal datasets with CRVS
to increase birth/death registration [70] and birthweight
capture, and in settings with a high proportion of home
births, links to intermittent surveys or population surveil-
lance may also be possible (Figure 1). Some countries are
now implementing maternal death surveillance and
response [71] and have begun to count maternal deaths in
real time. A few countries are also incorporating perinatal
death audits, which represents a key opportunity to
expand use and quality of perinatal audit data [72]. A
major focus is needed for inclusion of stillbirth rates in
reporting and accountability mechanisms, and especially
increasing data on intrapartum stillbirths. Further oppor-
tunities have been identified in increasing the coverage
and quality of CRVS and verbal autopsy to improve cause
of death estimates for maternal, neonatal and stillbirths
[73,74]. Substantial work is required on the additional
indicators measuring newborn morbidity, disability and
child development, which are critical to validate and insti-
tutionalise particularly as countries scale up neonatal
intensive care services (Figure 7).
Improving measurement of gestational age is essential
given that prematurity is the leading cause of newborn
deaths and deaths in children under five [75]. Preterm
birth is also a major risk factor for deaths from infections
and other morbidities [76]. Gestational age is an essential
part of clinical targeting of interventions to reduce morbid-
ity and mortality and can be measured both during preg-
nancy (using methods ranging from the dating of LMP to
using more resource intensive ultrasound scans) to clinical
assessments of the newborn. The skill sets needed for the
measurement approaches that are currently available are
different. Estimating gestational age using first trimester
ultrasound and the date of last menstrual period is stan-
dard in most HIC, but these methods are not available for
most women in LMIC. LMP recall is often poor or inaccu-
rate in settings with low literacy. Universal access to ultra-
sonography is unlikely to be available to large numbers of
women in LMIC in the shorter term, and/or mothers who
present late in pregnancy, when ultrasound dating is inac-
curate (+/- 3 weeks). Current work is looking at the poten-
tial for simplified tools for more accurate assessment of
gestational age [77], including simplified clinical tools, and
surrogate anthropometric measures that could be used by
community health workers [78-80]. Validation of new
methods in cohorts with early accurate ultrasonography
dating is a critical need. Feasible and innovative approaches
need to be validated in different regions, populations and
settings, across which their performance may vary.
Figure 7 Measurement improvement roadmap for coverage indicators (including care of small and sick newborns). DHS: Demographic
and Health Survey, HFA: Health Facility Assessment, HMIS: Health Management Information System, MICS: Multiple Indicator Cluster Survey, PPV:
positive predictive value, WHO: World Health Organization.
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Coverage indicators
The next five years demands an ambitious and systematic
process for data improvement (through effective partner-
ship) to address the gaps in newborn coverage indicators.
Shared goals across the MNH community will facilitate
metrics testing and help institutionalise capacity for sys-
tems to collect and use these data (Figure 1). In the short
term, desk-based testing and validation of indicator
Figure 8 Every Newborn Action Plan (ENAP) Measurement Improvement Roadmap. ENAP: Every Newborn Action Plan; HMIS: Health
Management Information System; WHO: World Health Organization.
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definitions using existing datasets (from LMIC) is
required. Additionally, these indicators need to be field-
tested in a range of settings. The research process for
validation of indicators involves collecting empirical data
through direct observations of care in a facility and
directly comparing this data with both health worker
reports and maternal recall of events. Relatively large
numbers of direct observations may be needed to ensure
sufficient sample power for estimating sensitivity and
specificity of the indicators using appropriate statistical
tests. Initial testing sites have been identified as part of
the measurement improvement roadmap (Figure 8).
Once finalised, testing protocols will be made available to
facilitate wide-scale testing across many different settings
to yield comparable results. Where indicator definitions
already exist and are being collected at scale, there is
potential to increase the quantity, quality and frequency
of the data (Figure 4). Crosscutting work on increasing
the availability, quality, and accuracy of birth weight and
gestational age assessment (both in pregnancy and the
neonatal period) is needed and will support the develop-
ment of more precise indicators. It is anticipated that
findings from these studies will inform refinements to
the proposed indicators before institutionalisation into
existing systems (Figure 7).
Household surveys for tracking coverage
Household surveys remain the primary data collection
method to estimate coverage of contacts with the health
system. The Population Council is carrying out ongoing
work to assess the validity of current indicators measur-
ing skilled attendance at birth [81]. Such work provides
invaluable evidence on the validity of maternal recall of
interventions at the time of birth, with MICS using two
year recall and DHS now using the last birth within two
years for some maternal and newborn indicators
(although collects data for a five year retrospective per-
iod). Even where recall achieves higher specificity (such
as location of birth or Caesarean-section), their infre-
quent cycles (currently averaging 5 years) and high cost
[82]) make population level surveys less sensitive for
annual programme planning and timely decision-making
[83]. Previous efforts to improve measurement of many
interventions have focused predominantly on household
surveys [12,26,84], including recent validation studies
from the Improving Coverage Measurement Group.
Many of the challenges of measuring the treatment of
pneumonia in children through household surveys, espe-
cially in identifying the true population of children with
pneumonia for the denominator [58], are also applicable
to measuring coverage of treatment of neonatal infec-
tions and other specific treatment interventions.
The sample size required to generate point estimates
of coverage of newborn interventions with sufficient
precision through household surveys is often too high;
even more so when attempting to consider equity, and
analyse by socioeconomic and demographic factors. For
chlorhexidine cord cleansing in settings where policy is
provision for all live births [25], data collection through
a household survey such as DHS could be feasible.
Other treatment indicators address subsets of newborns,
and therefore, sample sizes and recall issues may make
household surveys very challenging for coverage mea-
surement. For measurement of treatment indicators, the
results of the ENAP metrics process suggest a shift away
from household surveys towards a focus on facility
based data collection tools where these interventions
can be more feasibly and accurately measured, and a
range of denominators tested for use (Figure 9).
Facility data for tracking coverage
For most of the treatment interventions, KMC, ACS, and
currently most neonatal resuscitation and serious neona-
tal infection case management, policy recommendations
are focused largely on facility-based initiation or adminis-
tration. This has meant that preliminary task team work
has focused predominately on facility platforms (with the
exception of Chlorhexidine). Combined testing in a num-
ber of facilities of the range of treatment interventions
would enable more efficient testing of a range of numera-
tors and denominators for each intervention using the
same datasets, and help to harmonise and align indicators
with national and facility-level needs.
Where there is no denominator
Task teams found denominators the most technically
challenging issue for measurement of intervention indi-
cators and have identified a list of denominator options
for testing wherever possible. Where detailed datasets
are available with complete and accurate birthweight
and gestational age data (for example in higher or mid-
dle income settings), these will be analysed to test and
compare the simplified per 100 or per 1000 live births
denominator to a more precise indicator option to
ascertain correlation between risk and the more precise
indicator, and sensitivity to change over time.
In view of contextual variation, such as varying pre-
term birth rates, or pSBI in different countries, there
may be a need to define thresholds or upper and lower
limits for indicator values. The proportion of C-section
deliveries, for example, has been roughly benchmarked
against a threshold of 5-15% in order to highlight where
there is an unmet need (less than 5%) or to identify an
excess number of C-sections (more than 15%) within a
population [85-87]; this threshold is not without contro-
versy. Learning from such processes is important to set
realistic, useful ranges for countries to monitor whether
interventions are reaching a sufficient number of new-
borns within safe limits.
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Health management information systems
Work towards sustainable, real-time, locally owned and
used systems underlines the need for strengthening
national HMIS [83]. HMIS refers to health information
collected and routinely reported from health facilities
and districts (often from government or public sector
facilities only) and are an ideal platform to influence as
they are present in most settings, relatively inexpensive
(compared with large scale representative household
surveys) and largely driven by national decision makers.
Electronic platforms are evolving to support data collec-
tion, management, analysis and report generation, link-
ing to other systems including logistics management
(rather than external agencies). The emphasis for
strengthening HMIS needs to fall on improving the
validity of HMIS indicators and increasing the use of
this data for improving programme performance at the
ground level. Many settings are now using District
Health Information Systems 2 (DHIS 2)[88]. DHIS 2
software has a field-tested flexible data model with data
entry forms for indicators and the ability to support
data collection, management and analysis, including
generating reports to monitor indicator trends over time
and produce maps to visualise subnational variations for
identification of inequities. There is potential for new-
born treatment indicators (particularly KMC, ACS) to
be included in HMIS/ LMIS, SPAs and other facility
audits along with the supplies and equipment for ACS,
neonatal resuscitation and pSBI treatment in settings
where they do not already exist.
Before recommending inclusion of indicators into any
national data collection system, indicators will need test-
ing for validity and then for feasibility and usefulness, as
per the steps of the measurement improvement plan
(see Figure 1 and 7). Given the ongoing tension between
demand for more information for decision making, ver-
sus the need to be parsimonious with the number of
indicators to avoid overburdening frontline workers and
information systems, prioritisation of the ENAP treat-
ment indicators for inclusion in these systems should be
country specific and consider relevance to national pol-
icy and health system needs. Overloading an HMIS sys-
tem with data can limit its usefulness and negatively
affect data quality. In addition to validity testing, consid-
eration of national data needs, existing levels of facility,
infrastructure, resources and technical capacity is essen-
tial before introducing new indicators into a national
HMIS. Furthermore, data from HMIS may be more lim-
ited in settings where a large proportion of births take
place in the community (e.g. Ethiopia), or where there is
a large private sector (e.g. India).
Input and process data for tracking content and quality
of care
Given the challenges in measuring coverage for several of
the treatment interventions, appropriate process indica-
tors were identified that can be measured immediately.
For the purpose of this discussion, “process” data refers
to any measurement of the presence of specific elements
needed to deliver an intervention, such as supportive pol-
icy, trained staff, commodities, documentation or infra-
structure. Process data are not a replacement for
coverage data, but ensure a standardised proxy can be
used immediately. These data can be measured through a
variety of platforms, including HMIS, routine audits and/
or facility based supervision checklists. Additionally, peri-
odic or intermittent health facility assessments, such as
SPA [17] and service readiness assessments, such as
SARA [16] and EmOC needs assessments [15] monitor
process indicators. As many of the indicators (impact and
Figure 9 Large scale data collection platforms for coverage and process indicators. ✓ Already collected. * Feasible to collect. X=Not likely
to be feasible to collect (due to recall of numerator, denominator identification challenges, sample size issues). DHS: Demographic and Health
Surveys, MICS: Multiple Indicator Cluster Surveys, HMIS: health management information systems, SPA: Service performance assessments, SARA:
Service Availability and Readiness Assessments, EmOC: Emergency Obstetric Care.
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coverage) measured through household surveys require
relatively long periods of time to see significant change fol-
lowing policy adjustments, facility level programmatic data
is essential for measurement of more proximate factors in
the facility that are more amenable to change in the
shorter term. Furthermore, facility surveys can provide
external validation for self-reported data, such as those
emerging from HMIS. Harmonisation of core modules for
HFAs should include the priority ENAP process indicators
to maximise their use and allow for comparison between
surveys (Figure 9). However, the use of periodic health
facility assessments is expensive and does not replace rou-
tine supervision or programme monitoring.
Some task teams proposed indicators regarding exis-
tence of supporting policy at national level as a key mea-
sure of process. For example, the task teams for both
ACS and CHX proposed a measure of the number of
countries with ACS or CHX respectively on the essential
drug list since their addition is recent (2013) [37]; data
are collected in the RMNCH Trust data system and
reported in Countdown (Figures 5 and 6). Given that
these interventions are at an earlier point in policy to
programme change, these may be useful trackers for now
but as programme implementation accelerates, the pro-
cess indicator should be shifted to more proximal readi-
ness indicators and coverage.
The ENAP measurement improvement roadmap, in
partnership with other tracking data harmonisation
efforts, aims to test both simple and composite readiness
indicators for newborn interventions, considering the
presence of essential commodities, trained staff, and
space.
Care of small and sick babies
There is a major gap in the definition of standards for the
care of small and sick newborns; the provision of quality
inpatient care for small and sick babies could have a signif-
icant impact on neonatal deaths [9]. The UN EmOC indi-
cators are based on process indicators referred to as
“signal functions” for basic and comprehensive emergency
obstetric care [18]; currently only one signal function spe-
cifically relates to newborn care, but does not fully repre-
sent all interventions needed for emergency newborn care.
New research supports the addition of signal functions
specific to newborn care and strongly recommends that
these indicators should be updated [89]. Specific chal-
lenges and details on the levels of care are explained in
greater detail elsewhere in the series [90] and ENAP
recommends an ongoing process with the UN to define
indicators for newborn care intervention packages by
levels of care.
As a milestone from ENAP linked to EPMM, addres-
sing quality of care at birth is critical; the Every Mother,
Every Newborn (EMEN) Initiative is part of this process
as discussed in paper 1 of this supplement [91].
Challenges and opportunities going forward
Integrating maternal health and broader roadmaps for
improving metrics
It is essential to unite maternal and neonatal health
communities towards a common metrics agenda with a
convergence of global efforts to end preventable mortal-
ity and coordinated support to countries to assess pro-
gress meeting targets set within the SDGs, ENAP and
the ending preventable maternal mortality movement
(EPMM). These functions are the remit of the WHO,
other UN agencies and academic partners, and can be
aligned through the creation of an over-arching MNH
reference group. This remit will also aim to link existing
work and relevant convening groups, including those
working on wider metrics systems change.
Intentional development of leadership to assess, improve
and use data
In order to institutionalise the proposed metrics, there is
a need to build leadership skills to assess and use data in
high burden settings (Figure 8). These include INDEPTH
Network’s Maternal and Newborn Working Group,
which aims to improve population-based metrics, espe-
cially pregnancy tracking, mortality, cause of death and
social autopsy, birthweight and gestational age.
INDEPTH is a network of currently 52 health and demo-
graphic surveillance sites (HDSS) in twenty countries
where a total population of 3.8 million people are tracked
each year. The Maternal and Newborn Working Group
is building the capacity of member sites to use standar-
dised tools and to make data regularly available to the
public. The All India Institute of Medical Sciences/WHO
Collaborating Centre for Newborn Care is well placed to
develop a simplified database for follow up of at risk neo-
nates, track and minimise disability outcomes and maxi-
mise child development, especially preterm, for example
preventing blindness from retinopathy of prematurity
[92,93]. ENAP is identifying provisional country hubs for
testing of proposed indicator numerators and denomina-
tors initially linked to focus countries for EMEN.
Conclusions
Major gaps have been identified in the measurement of
core ENAP indicators to track the progress towards tar-
gets to end preventable deaths for women, stillbirths,
newborns and children; key messages and action points
are summarised in Figure 10. The quality and quantity of
impact data must be improved, but coverage indicators
need the most urgent work. Content and quality of care
is the current priority for the three contact point indica-
tors. For the treatment indicators, preliminary work to
identify measurable denominators is required in prepara-
tion for the quality improvement agenda. The findings of
this work underline the need for increasing prioritisation
for strengthening and improving routine facility based
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data, CRVS and national HMIS. This paper has laid out a
systematic, yet ambitious testing agenda - the ENAP
Measurement Improvement Roadmap - to move towards
use of these indicators at scale, which must be combined
with an intentional transfer of technical leadership, espe-
cially to countries with the greatest disease burden. The
strengthening of institutional capability to collect, analyse
and convert data into action is essential. By 2020, the aim
is to institutionalise the proposed metrics at scale across
all countries. A roadmap that focuses on counting births,
deaths and improves tracking of coverage and equity is
central to support countries to build a strong national
Figure 10 Key messages and action points. ENAP: Every Newborn Action Plan; HMIS: health management information systems.
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data system that can be used to inform policy and focus
investment and resources towards quality service delivery
for every newborn to have the chance of a healthy start
in life [6].
Additional material
Additional file 1: Listing of relevant indicators according to level of the
impact framework (from impact down to inputs).
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